„First Line“

Suchergebnisse

3.416 Treffer

• Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study
  Chang, Jinjia ; Lin, Guangyi ; Ye, Min ; Tong, Duo ; Zhao, Jing ; Zhu, Dan ; Yu, Qihe ; Zhang, Wen ; Li, Wenhua
• Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation
  Tanaka, Kazuhiro ; Kawano, Masanori ; Iwasaki, Tatsuya ; Itonaga, Ichiro ; Tsumura, Hiroshi
• Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?
  Vogl, Ursula M. ; Andalibi, Haleh ; Klaus, Alexander ; Vormittag, Laurenz ; Schima, Wolfgang ; Heinrich, Bettina ; Kafka, Alice ; Winkler, Thomas ; Öhler, Leopold
• Viral load detection and management on first line ART in rural Rwanda
  Ndagijimana Ntwali, Jean de Dieu ; Decroo, Tom ; Ribakare, Muhayimpundu ; Kiromera, Athanase ; Mugwaneza, Placidie ; Nsanzimana, Sabin ; Lynen, Lutgarde
• Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
  Fonseca, Leonardo Gomes da ; Marta, Guilherme Nader ; Braghiroli, Maria Ignez Freitas Melro ; Chagas, Aline Lopes ; Carrilho, Flair Jose ; Hoff, Paulo Marcelo ; Sabbaga, Jorge
• ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk “BCG failure” non muscle invasive bladder cancer: 3 years follow-up outcomes
  Racioppi, Marco ; Di Gianfrancesco, Luca ; Ragonese, Mauro ; Palermo, Giuseppe ; Sacco, Emilio ; Bassi, Pier Francesco
• Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
  Wu, Bin ; Zhang, Qiang ; Sun, Jie
• Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
  Al-Nadaf, Sami ; Rebhun, Robert B. ; Curran, Kaitlin M. ; Venable, Rachel O. ; Skorupski, Katherine A. ; Willcox, Jennifer L. ; Burton, Jenna H.
• Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis
  Chiu, Keith W. H. ; Lam, Ka-On ; An, H. ; Cheung, Gavin T. C. ; Lau, Johnny K. S. ; Choy, Tim-Shing ; Lee, Victor H. F.
• The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy
  Tampellini, M. ; Ottone, A. ; Alabiso, I. ; Baratelli, C. ; Forti, L. ; Berruti, A. ; Aroasio, E. ; Scagliotti, G. V.
• Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial
  Kato, Tadashi ; Furukawa, Toshi A. ; Mantani, Akio ; Kurata, Ken’ichi ; Kubouchi, Hajime ; Hirota, Susumu ; Sato, Hirotoshi ; Sugishita, Kazuyuki ; Chino, Bun ; Itoh, Kahori ; Ikeda, Yoshio ; Shinagawa, Yoshihiro ; Kondo, Masaki ; Okamoto, Yasumasa ; Fujita, Hirokazu ; Suga, Motomu ; Yasumoto, Shingo ; Tsujino, Naohisa ; Inoue, Takeshi ; Fujise, Noboru ; Akechi, Tatsuo ; Yamada, Mitsuhiko ; Shimodera, Shinji ; Watanabe, Norio ; Inagaki, Masatoshi ; Miki, Kazuhira ; Ogawa, Yusuke ; Takeshima, Nozomi ; Hayasa
• Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial
  Hayashida, Tetsu ; Jinno, Hiromitsu ; Mori, Katsuaki ; Sato, Hiroki ; Matsui, Akira ; Sakurai, Takashi ; Hattori, Hiroaki ; Takayama, Shin ; Wada, Masahiro ; Takahashi, Maiko ; Seki, Hirohito ; Seki, Tomoko ; Nagayama, Aiko ; Matsumoto, Akiko ; Kitagawa, Yuko
• Identifying levels of general distress in first line mental health services: can GP- and eHealth clients’ scores be meaningfully compared?
  van Bebber, Jan ; Wigman, Johanna T. W. ; Wunderink, Lex ; Tendeiro, Jorge N. ; Wichers, Marieke ; Broeksteeg, Janneke ; Schrieken, Bart ; Sytema, Sjoerd ; Terluin, Berend ; Meijer, Rob R.
• Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial
  Markóczy, Zsolt ; Sárosi, Veronika ; Kudaba, Iveta ; Gálffy, Gabriella ; Turay, Ülkü Yilmaz ; Demirkazik, Ahmet ; Purkalne, Gunta ; Somfay, Attila ; Pápai-Székely, Zsolt ; Rásó, Erzsébet ; Ostoros, Gyula
• Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
  Li, Lei ; Wan, Xirun ; Feng, Fengzhi ; Ren, Tong ; Yang, Junjun ; Zhao, Jun ; Jiang, Fang ; Xiang, Yang
• Modeling and simulation of maintenance treatment in first-line non-small cell lung cancer with external validation
  Han, Kelong ; Claret, Laurent ; Sandler, Alan ; Das, Asha ; Jin, Jin ; Bruno, Rene
• Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
  Tan, Ping-Tee ; Aziz, Mohamed Ismail Abdul ; Pearce, Fiona ; Lim, Wan-Teck ; Wu, David Bin-Chia ; Ng, Kwong
• GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer
  Zhao, Dan ; Wang, Xiaobing ; Zhang, Wei
• Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016
  Ikeda, Satoshi ; Kato, Terufumi ; Ogura, Takashi ; Sekine, Akimasa ; Oda, Tsuneyuki ; Masuda, Noriyuki ; Igawa, Satoshi ; Katono, Ken ; Otani, Sakiko ; Yamada, Kouzo ; Saito, Haruhiro ; Kondo, Tetsuro ; Hosomi, Yukio ; Nakahara, Yoshiro ; Nishikawa, Masanori ; Utumi, Keiko ; Misumi, Yuki ; Yamanaka, Takeharu ; Sakamaki, Kentaro ; Okamoto, Hiroaki
• A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
  Engel-Riedel, Walburga ; Lowe, Jamie ; Mattson, Paulette ; Richard Trout, J. ; Huhn, Richard D. ; Gargano, Michele ; Patchen, Myra L. ; Walsh, Richard ; Trinh, My My ; Dupuis, Mariève ; Schneller, Folker